Cargando…
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells
Androgen deprivation therapy is initially effective for treating patients with advanced prostate cancer; however, the prostate cancer gradually becomes resistant to androgen deprivation therapy, which is termed castration‐resistant prostate cancer (CRPC). Androgen receptor splice variant 7 (AR‐V7),...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581527/ https://www.ncbi.nlm.nih.gov/pubmed/28691182 http://dx.doi.org/10.1111/cas.13318 |